These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 24935573

  • 1. Application of tumor markers SCC-Ag, CEA, and TPA in patients with cervical precancerous lesions.
    Farzaneh F, Shahghassempour S, Noshine B, Arab M, Yaseri M, Rafizadeh M, Alizadeh K.
    Asian Pac J Cancer Prev; 2014; 15(9):3911-4. PubMed ID: 24935573
    [Abstract] [Full Text] [Related]

  • 2. Pretreatment plasma levels and diagnostic utility of hematopoietic cytokines in cervical cancer or cervical intraepithelial neoplasia patients.
    Ławicki S, Będkowska GE, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Folia Histochem Cytobiol; 2012 Jul 04; 50(2):213-9. PubMed ID: 22763962
    [Abstract] [Full Text] [Related]

  • 3. Determination of serum levels of different cytokeratins in patients with uterine malignancies.
    Ferdeghini M, Gadducci A, Prontera C, Castellani C, Annicchiarico C, Gagetti O, Facchini V, Bianchi R.
    Anticancer Res; 1994 Jul 04; 14(3B):1393-7. PubMed ID: 7520682
    [Abstract] [Full Text] [Related]

  • 4. Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by a stratification analysis.
    Yuan CC, Wang PH, Ng HT, Tsai LC, Juang CM, Chiu LM.
    Eur J Gynaecol Oncol; 2002 Jul 04; 23(1):17-20. PubMed ID: 11876385
    [Abstract] [Full Text] [Related]

  • 5. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    Sidorkiewicz I, Zbucka-Krętowska M, Zaręba K, Lubowicka E, Zajkowska M, Szmitkowski M, Gacuta E, Ławicki S.
    BMC Cancer; 2019 Apr 29; 19(1):398. PubMed ID: 31035945
    [Abstract] [Full Text] [Related]

  • 6. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Yoon SM, Shin KH, Kim JY, Seo SS, Park SY, Kang S, Cho KH.
    Int J Gynecol Cancer; 2007 Apr 29; 17(4):872-8. PubMed ID: 17343571
    [Abstract] [Full Text] [Related]

  • 7. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P.
    Anticancer Res; 1997 Apr 29; 17(3C):2329-34. PubMed ID: 9245246
    [Abstract] [Full Text] [Related]

  • 8. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH, Lee SW, Yu M, Jeong S, Lee JW, Lee JH.
    J Gynecol Oncol; 2019 Jan 29; 30(1):e1. PubMed ID: 30479085
    [Abstract] [Full Text] [Related]

  • 9. Serum SCC-Ag in head and neck squamous cell carcinoma.
    Palermo F, Carniato A, Fede A, Boccaletto F, Marchiori C.
    Int J Biol Markers; 1990 Jan 29; 5(3):118-20. PubMed ID: 2286775
    [Abstract] [Full Text] [Related]

  • 10. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 29; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
    Lam CP, Yuan CC, Jeng FS, Tsai LC, Yeh SH, Ng HT.
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul 29; 50(1):7-13. PubMed ID: 1326391
    [Abstract] [Full Text] [Related]

  • 12. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
    Kanda M, Koike M, Shimizu D, Tanaka C, Kobayashi D, Hattori N, Hayashi M, Omae K, Yamada S, Nakayama G, Kodera Y.
    Ann Surg Oncol; 2020 Apr 29; 27(4):1233-1240. PubMed ID: 31650302
    [Abstract] [Full Text] [Related]

  • 13. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX, Wang Y, Xu XQ, Sun T, Tian BG, Du LL, Zhao XW, Han CZ.
    Asian Pac J Cancer Prev; 2014 Apr 29; 15(23):10267-72. PubMed ID: 25556459
    [Abstract] [Full Text] [Related]

  • 14. Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancer.
    Hefler L, Frischmuth K, Heinze G, Sliutz G, Leodolter S, Reinthaller A, Kainz C, Tempfer C.
    Int J Cancer; 1999 Oct 08; 83(2):167-70. PubMed ID: 10471522
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CEA, TPA, CA 19-9, SCC and CYFRA at diagnosis and in the follow-up of anal canal tumors.
    Indinnimeo M, Reale MG, Cicchini C, Stazi A, Fiori E, Izzo P.
    Int Surg; 1997 Oct 08; 82(3):275-9. PubMed ID: 9372374
    [Abstract] [Full Text] [Related]

  • 20. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
    Choi KH, Yu M, Jeong S, Lee JH.
    Int J Clin Oncol; 2020 Jul 08; 25(7):1405-1411. PubMed ID: 32221801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.